Rohto Pharmaceutical: Notice regarding the management system
Rohto Pharmaceutical: Consolidated financial results for the first fiscal quarter ending on March 31, 2025 (for the three months until June 30, 2024) have been updated.
Rohto Pharmaceutical: Consolidated financial results for the first quarter of the fiscal year ending March 31, 2025 (three months until June 30, 2024).
Rohto Pharmaceutical: Consolidated financial results for the first quarter of the fiscal year ending March 31, 2025 (three months until June 30, 2024).
Rohto Pharmaceutical: Announcement of revisions to financial estimates and dividend estimates (increased dividends).
Rohto Pharmaceutical: Announcements of individual stocks related to the naming of the event space under the symbolic large roof of Umekita Park, "Lotte Heart Square Umekita" has been determined.
Rohto Pharmaceutical: Announcements of individual stocks regarding investment in BAIBYS Fertility Ltd., a development venture that provides a new solution for infertility treatment.
Rohto Pharmaceutical: Investment in ZEROCO Corporation and establishment of a partnership for food business strategy.
Rohto Pharmaceutical: (Progress of Disclosure) Announcement of extension of the tender offer period for shares of Eu Yan Sang International Ltd., a Singaporean traditional chinese medicine manufacturing and sales company.
Rohto Pharmaceutical: Announcements of individual stocks regarding the new management structure.
Rohto Pharmaceutical: 【Correction and Apology】Rohto Pharmaceutical and Recursive, an AI startup, have entered into a capital business partnership to realize a well-being society using AI.
Rohto Pharmaceutical: Rohto Pharmaceutical and AI startup Recursive have entered into a capital business partnership to realize a well-being society using AI.
Rohto Pharmaceutical: Independent Company Executives Declaration
Rohto Pharmaceutical: Acquisition of shares in the Austrian pharmaceutical company Mono Chemical Farm Products.
Rohto Pharmaceutical: Regarding the acquisition of shares of Mono chem-pharm Produkte GmbH, an Austrian pharmaceutical company.
Rohto Pharmaceutical: Announcements of individual stocks regarding the public tender offer for shares of Eu Yan Sang International Ltd., a Singaporean traditional chinese medicine manufacturer and distributor, by Soar R2M Pte. Ltd.
Rohto Pharmaceutical: [Corrections and apologies] Notice regarding changes in officers
Rohto Pharmaceutical: Notice regarding changes in officers
Rohto Pharmaceutical: Consolidated financial results for the fiscal year ended March 31, 2024
Rohto Pharmaceutical: [Update] [Postponed] Stock Acquisition and Tender Offer for Yu Yangsan International Co., Ltd.
No Data
No Data